Sathekge, M., Kratochwil, C., & Giesel, F. L. (2020). Predictors of overall and disease-free survival in metastatic castration-resistant prostate cancer patients receiving 225Ac-PSMA-617 radioligand therapy. Journal of nuclear medicine, 61(1), . https://doi.org/10.2967/jnumed.119.229229
Chicago-Zitierstil (17. Ausg.)Sathekge, Mike, Clemens Kratochwil, und Frederik L. Giesel. "Predictors of Overall and Disease-free Survival in Metastatic Castration-resistant Prostate Cancer Patients Receiving 225Ac-PSMA-617 Radioligand Therapy." Journal of Nuclear Medicine 61, no. 1 (2020). https://doi.org/10.2967/jnumed.119.229229.
MLA-Zitierstil (9. Ausg.)Sathekge, Mike, et al. "Predictors of Overall and Disease-free Survival in Metastatic Castration-resistant Prostate Cancer Patients Receiving 225Ac-PSMA-617 Radioligand Therapy." Journal of Nuclear Medicine, vol. 61, no. 1, 2020, https://doi.org/10.2967/jnumed.119.229229.